TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company's Runway into Late 2027/Early 2028

Go back to TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company's Runway into Late 2027/Early 2028
(NASDAQ: RNAZ) Delayed: 4.97 -0.27 (5.15%)
Previous Close $5.24    52 Week High
Open $5.15    52 Week Low
Day High $5.33    P/E N/A 
Day Low $4.97    EPS
Volume 3,824